Jean N Westenberg
Biographic Data
| ID | 7181768 |
|---|---|
| NAME | Jean N Westenberg |
| GIVEN NAMES | Jean N |
| FAMILY NAME | Westenberg |
| SIGNATURE | WESTENBERG J N |
| AFFILIATIONS | University of British Columbia |
| ORCID | 0000-0002-4720-8402 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Cohort Profile: The Austrian National Opioid Agonist Treatment Cohort (OAT-AT)
The Austrian National Opioid Agonist Treatment (OAT-AT) cohort comprises all participants recorded in the pseudonymised statistical sub-registry of the national, open-ended OAT registry since its initiation in January 1, 2002 through December 31, 2019. Data linkage with the Austrian national death registry took place until December 31, 2021. Whereas the OAT registry primarily serves administrative monitoring, OAT-AT links its statistical sub-regi…
Sexual dysfunction prevalence, risk factors, and help-seeking behavior in opioid agonist treatment and general psychiatry: A cross-sectional study
SD are common among psychiatric patients receiving OAT and general psychiatric patients seeking psychotherapy. Professionals providing mental healthcare to patients must emphasize prevention and routine assessments of sexual functioning needs
Substance of choice, impact of heroin or opium on treatment retention in a multicentre randomised controlled trial in Iran
Developing A Rapid Transfer from Opioid Full Agonist to Buprenorphine: “Ultrarapid Micro-Dosing” Proof of Concept
Buprenorphine/naloxone has been shown to be effective for treating opioid use disorder (OUD). However, the traditional method of induction requires a patient to be in moderate-to-severe withdrawal, which is challenging, time-consuming, and a common reason for leaving against medical advice. Induction strategies that minimize the severity and duration of patient discomfort while enabling patients to reach therapeutic doses during short hospital ad…
Chronic Pain among Individuals Experiencing Homelessness and Its Interdependence with Opioid and Other Substance Use and Mental Illness
Chronic pain and substance use disorders are serious conditions that are prevalent among homeless populations. The aim of this study was to examine the association between chronic pain and substance use among individuals experiencing homelessness and mental illness. We analyzed cross-sectional data from two sites of the At Home/Chez Soi study (Vancouver and Toronto) using bivariate statistics and multivariate logistic regression. Substance use an…
No prominent works on this page.
Chronic Pain among Individuals Experiencing Homelessness and Its Interdependence with Opioid and Other Substance Use and Mental Illness
Chronic pain and substance use disorders are serious conditions that are prevalent among homeless populations. The aim of this study was to examine the association between chronic pain and substance use among individuals experiencing homelessness and mental illness. We analyzed cross-sectional data from two sites of the At Home/Chez Soi study (Vancouver and Toronto) using bivariate statistics and multivariate logistic regression. Substance use an…
Substance of choice, impact of heroin or opium on treatment retention in a multicentre randomised controlled trial in Iran
Developing A Rapid Transfer from Opioid Full Agonist to Buprenorphine: “Ultrarapid Micro-Dosing” Proof of Concept
Buprenorphine/naloxone has been shown to be effective for treating opioid use disorder (OUD). However, the traditional method of induction requires a patient to be in moderate-to-severe withdrawal, which is challenging, time-consuming, and a common reason for leaving against medical advice. Induction strategies that minimize the severity and duration of patient discomfort while enabling patients to reach therapeutic doses during short hospital ad…
Sexual dysfunction prevalence, risk factors, and help-seeking behavior in opioid agonist treatment and general psychiatry: A cross-sectional study
SD are common among psychiatric patients receiving OAT and general psychiatric patients seeking psychotherapy. Professionals providing mental healthcare to patients must emphasize prevention and routine assessments of sexual functioning needs
Cohort Profile: The Austrian National Opioid Agonist Treatment Cohort (OAT-AT)
The Austrian National Opioid Agonist Treatment (OAT-AT) cohort comprises all participants recorded in the pseudonymised statistical sub-registry of the national, open-ended OAT registry since its initiation in January 1, 2002 through December 31, 2019. Data linkage with the Austrian national death registry took place until December 31, 2021. Whereas the OAT registry primarily serves administrative monitoring, OAT-AT links its statistical sub-regi…
Opioid (5 works) · Internal Medicine (4 works) · Medicine (4 works) · Opioid Use Disorder Treatment (3 works) · Psychiatry (3 works) · Agonist (2 works) · Cross-sectional study (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Logistic regression (2 works) · Pain Management and Opioid Use (2 works)